Related references
Note: Only part of the references are listed.Adult-type granulosa cell tumor of the ovary: a FOXL2-centric disease
Jessica A. Pilsworth et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2021)
Reply to An alternative miRISC targets a cancer-associated coding sequence mutation in FOXL2
Reiner A. Veitia et al.
EMBO JOURNAL (2021)
FOXL2 in adult-type granulosa cell tumour of the ovary: oncogene or tumour suppressor gene?
Jessica A. Pilsworth et al.
JOURNAL OF PATHOLOGY (2021)
Mutant FOXL2C134W Hijacks SMAD4 and SMAD2/3 to Drive Adult Granulosa Cell Tumors
Stine E. Weis-Banke et al.
CANCER RESEARCH (2020)
The Pathognomonic FOXL2 C134W Mutation Alters DNA-Binding Specificity
Annaick Carles et al.
CANCER RESEARCH (2020)
An alternative miRISC targets a cancer‐associated coding sequence mutation in FOXL2
Eunkyoung Shin et al.
EMBO JOURNAL (2020)
Impact of FOXL2 mutations on signaling in ovarian granulosa cell tumors
Dilys T. H. Leung et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2016)
Molecular Pathogenesis of Granulosa Cell Tumors of the Ovary
Stacey Jamieson et al.
ENDOCRINE REVIEWS (2012)
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary
Stacey Jamieson et al.
MODERN PATHOLOGY (2010)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
